Events - Page 3

Time and place: Feb. 10, 2015 12:00 PM - 1:00 PM, Ciens Via, Forskningsparken

Petr Bartunek is group leader at the Institute of Molecular Genetics (IMG) in Prague and Director of CZ-OPENSCREEN: National Infrastructure for Chemical Biology. His research is focused on understanding molecular mechanism of cell fate determination. They use growth factors and small molecules to manipulate processes of hematopoietic and neural stem cell self-renewal and differentiation. More recently, they have pioneered ex vivo hematopoietic cell culture techniques in zebrafish that enable analysis of normal and leukemic hematopoiesis. The title of his talk is “Dissecting blood development using zebrafish”.

Time and place: Feb. 4, 2015 9:15 AM - 10:00 AM, Ciens Via, Forskningsparken

Professor Olivier Poetz is employed at The Natural and Medical Sciences Institute (NMI) at the University of Tübingen and his lecture is titled 'Immunoassays: High Sensitivity, High Specificity, High Speed for, any Type of Analyte, and Clinical Specimen'

Time and place: Feb. 3, 2015 12:00 PM - 1:00 PM, Ciens Via, Forskningsparken

Professor Anders Sundan is heading the K.G. Jebsen Center for Myeloma Research that was established at the Norwegian University of Science and Technology (NTNU) in 2012. Sundan and his team focus on why cancer cells survive in the bone marrow in myeloma cases. In particular, they are interested in  differences between cancer cells and normal cells at the DNA and protein level. The research group also investigates why some cancer cells are sensitive to treatment whereas others are resistant.

'Multiple Myeloma – clinical problem and cancer model' is his presentation for the Hans Prydz Guest Lecture series.

Time and place: Nov. 25, 2014 2:00 PM - 3:45 PM, Forum (Ground floor, Oslo Science Park)

Krister Wennerberg is heading the Cancer Chemical Systems Biology Group at the Institute for Molecular Medicine Finland (FIMM), Nordic EMBL Partnership. His Research group is focused on gaining fundamental novel understanding of cancers and their phenotypes using a chemical systems biology approach. Bjørn Tore Gjertsen is Professor in hematology at the Department of Clinical Science at the University of Bergen. Wennerberg and Gjertsen will lecture on drug sensitivity testing and personalized medicine in leukemia.